| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |